AT336566B - Verfahren zur herstellung von neuen p-(2'-aminoalkyl)anilinen und deren saureadditionssalzen - Google Patents

Verfahren zur herstellung von neuen p-(2'-aminoalkyl)anilinen und deren saureadditionssalzen

Info

Publication number
AT336566B
AT336566B AT702574A AT702574A AT336566B AT 336566 B AT336566 B AT 336566B AT 702574 A AT702574 A AT 702574A AT 702574 A AT702574 A AT 702574A AT 336566 B AT336566 B AT 336566B
Authority
AT
Austria
Prior art keywords
anilines
aminoalkyl
preparation
new
acid addition
Prior art date
Application number
AT702574A
Other languages
English (en)
Other versions
ATA702574A (de
Inventor
Gosta Lennart Florvall
Svante Bertil Ross
Sven-Ove Ogren
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE7312001A external-priority patent/SE382047B/xx
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Priority to AT415476A priority Critical patent/AT340386B/de
Publication of ATA702574A publication Critical patent/ATA702574A/de
Application granted granted Critical
Publication of AT336566B publication Critical patent/AT336566B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
AT702574A 1973-09-04 1974-08-30 Verfahren zur herstellung von neuen p-(2'-aminoalkyl)anilinen und deren saureadditionssalzen AT336566B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT415476A AT340386B (de) 1973-09-04 1976-06-08 Verfahren zur herstellung von neuen p- (2'-aminoalkyl)-anilinen und deren saureadditionssalzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7312001A SE382047B (sv) 1973-09-04 1973-09-04 Forfarande for framstellning av 4-aminoamfetaminderivat

Publications (2)

Publication Number Publication Date
ATA702574A ATA702574A (de) 1976-09-15
AT336566B true AT336566B (de) 1977-05-10

Family

ID=20318423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT702574A AT336566B (de) 1973-09-04 1974-08-30 Verfahren zur herstellung von neuen p-(2'-aminoalkyl)anilinen und deren saureadditionssalzen

Country Status (16)

Country Link
US (1) US3996381A (de)
JP (1) JPS5835177B2 (de)
AT (1) AT336566B (de)
BE (1) BE819515A (de)
CA (1) CA1051436A (de)
CH (2) CH603547A5 (de)
DE (1) DE2440734C2 (de)
DK (1) DK139716B (de)
FI (1) FI62281C (de)
FR (1) FR2242079B1 (de)
GB (1) GB1461667A (de)
HK (1) HK75778A (de)
IE (1) IE40514B1 (de)
LU (1) LU70852A1 (de)
NL (1) NL7411753A (de)
NO (2) NO139408C (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070117869A1 (en) * 2000-11-01 2007-05-24 Cognition Pharmaceuticals Llc Methods for treating coginitive impairment and improving cognition
US20030119884A1 (en) * 2000-11-01 2003-06-26 Epstein Mel H. Methods and compositions for regulating memory consolidation
US7619005B2 (en) * 2000-11-01 2009-11-17 Cognition Pharmaceuticals Llc Methods for treating cognitive impairment in humans with Multiple Sclerosis
US20050059743A1 (en) * 2000-11-01 2005-03-17 Sention, Inc. Methods for treating mild cognitive impairment and alzheimer's disease
US20030232890A1 (en) * 2000-11-01 2003-12-18 Sention, Inc. Methods for treating an impairment in memory consolidation
WO2002039998A2 (en) * 2000-11-01 2002-05-23 Sention, Inc. Methods and compositions for regulating memory consolidation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117160A (en) * 1961-07-27 1964-01-07 Pfizer & Co C Aralkylamines
US3496195A (en) * 1966-05-11 1970-02-17 Chinoin Gyogyszer Es Vegyeszet D-o-bromo-phenyl-isopropyl-methylpropinylamine and its salts

Also Published As

Publication number Publication date
IE40514B1 (en) 1979-06-20
NO139408C (no) 1979-03-07
ATA702574A (de) 1976-09-15
NL7411753A (nl) 1975-03-06
CA1051436A (en) 1979-03-27
NO791507L (no) 1975-03-05
FI62281B (fi) 1982-08-31
US3996381A (en) 1976-12-07
FI62281C (fi) 1982-12-10
FI257674A (de) 1975-03-05
IE40514L (en) 1975-03-04
NO142624C (no) 1980-09-17
NO142624B (no) 1980-06-09
FR2242079B1 (de) 1978-07-21
NO743177L (de) 1975-04-01
FR2242079A1 (de) 1975-03-28
DK464774A (de) 1975-05-05
CH599106A5 (de) 1978-05-12
BE819515A (fr) 1975-03-04
JPS5835177B2 (ja) 1983-08-01
DK139716B (da) 1979-04-02
DK139716C (de) 1979-09-17
AU7283374A (en) 1976-03-04
NO139408B (no) 1978-11-27
LU70852A1 (de) 1975-06-11
GB1461667A (en) 1977-01-19
DE2440734A1 (de) 1975-03-13
CH603547A5 (de) 1978-08-31
HK75778A (en) 1979-01-05
JPS5050329A (de) 1975-05-06
DE2440734C2 (de) 1985-01-24

Similar Documents

Publication Publication Date Title
ATA195476A (de) Verfahren zur herstellung von neuen p-trifluormethyl-acylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen
AT330150B (de) Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
AT350054B (de) Verfahren zur herstellung von neuen 1,5,10,10a- tetrahydrothiazolo-(3,4-b)-isochinolin- derivaten und von deren saeureadditionssalzen
AT336030B (de) Verfahren zur herstellung von neuen naphthyridinderivaten und von deren saureadditionssalzen
AT336566B (de) Verfahren zur herstellung von neuen p-(2'-aminoalkyl)anilinen und deren saureadditionssalzen
ATA195576A (de) Verfahren zur herstellung von neuen p-halogen-acylophenon- o - (2-aminoathyl)-oximathern und deren saureadditionssalzen
AT335997B (de) Verfahren zur herstellung von neuen n'-(aminoacylaminophenyl)-acetamidinen und deren saureadditionssalzen
ATA194876A (de) Verfahren zur herstellung von neuen p-methylthioacylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen
AT324354B (de) Verfahren zur herstellung von neuen n-phenyl-n'-dialkylphosphinylalkylpiperazinen und von deren säureadditionssalzen
AT352735B (de) Verfahren zur herstellung von neuen 2,4- diamino-5-benzylpyrimidinen und deren saeure- additionssalzen
AT340051B (de) Verfahren zur herstellung von neuen 2-deoxystreptaminaminoglykosiden und deren saureadditionssalzen
ATA415476A (de) Verfahren zur herstellung von neuen p- (2'-aminoalkyl)-anilinen und deren saureadditionssalzen
ATA195276A (de) Verfahren zur herstellung von neuen p-nitro-acylophenon-o- (2-aminoathyl) -oximather und deren saureadditionssalzen
ATA195176A (de) Verfahren zur herstellung von neuen p-methylsulfinyl-acylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen
AT341525B (de) Verfahren zur herstellung von neuen imidazolido- (1,5-c)-thiazolidin-3-spiro-4'-piperadinen und deren saureadditionssalzen
AT338783B (de) Verfahren zur herstellung von neuen derivaten des 1-phenoxy-3-aminopropan-2-ols und deren saureadditionssalzen
AT340422B (de) Verfahren zur herstellung von neuen dibenzyl-glykolsaurederivaten und deren salzen
ATA296675A (de) Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
ATA296975A (de) Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
ATA296775A (de) Verfahren zur herstellung von neuen 1-phenoxy -2-hydroxy-3- propargylaminopropanen und von deren saureadditionssalzen
ATA296575A (de) Verfahren zur herstellung von neuen 1- cyanophenoxy-2-hydroxy-3-propargylaminopropanen und von deren saureadditionssalzen
ATA297075A (de) Verfahren zur herstellung von neuen 1- phenoxy-2- hydroxy-3-propargylaminopropanen und von deren saureadditionssalzen
ATA296475A (de) Verfahren zur herstellung von neuen 1-cyanophenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
ATA720575A (de) Verfahren zur herstellung von neuen 2,6-methano-3-benzazocinen und deren saureadditionssalzen
ATA816877A (de) Verfahren zur herstellung von neuen 2,6-methano-3-benzazocinen und deren saureadditionssalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee